Pomalidomide therapy for myeloma

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.20, Iss.5, 2011-05, pp. : 691-700

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic evaluation of pomalidomide for the treatment of myeloma

By Gay Francesca Mina Roberto Troia Rossella Bringhen Sara

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 11, 2013-11 ,pp. : 1517-1527

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic monoclonal antibodies in combination with pomalidomide can overcome refractoriness to both agents in multiple myeloma: A case‐based approach

Hematological Oncology (Electronic), Vol. 36, Iss. 1, 2018-02 ,pp. : 258-261

John Wiley & Sons Inc

Access to resources Recommend Favorite

Novel therapy in multiple myeloma

By Avilés Agustin Neri Natividad Nambo M. Cleto Sergio Castañeda Claudia González Martha Talavera Alejandra Huerta-Guzmán Judith

Investigational New Drugs, Vol. 23, Iss. 5, 2005-10 ,pp. : 411-415

Springer Publishing Company

Access to resources Recommend Favorite

Gene therapy for Multiple Myeloma

Current Gene Therapy, Vol. 8, Iss. 4, 2008-08 ,pp. : 247-255

Bentham Science Publishers

Access to resources Recommend Favorite

Current Drug Therapy for Multiple Myeloma

By Huang Y-W. Hamilton A. Arnuk O.J. Chaftari P. Chemaly R.

Drugs, Vol. 57, Iss. 4, 1999-04 ,pp. : 485-506

Adis International

Access to resources Recommend Favorite